| |
General obesity (BMI ≥ 25 kg/m2)
|
Abdominal obesity (WC ≥80 cm)
|
|---|
|
T1
|
T2
|
T3
|
P for trend
|
T1
|
T2
|
T3
|
P for trend
|
|---|
|
total BCAA
|
|
cases/total
|
48/141
|
42/141
|
38/141
| |
60/141
|
63/141
|
55/141
| |
|
Median (IQR) intake (g/d)a
|
4.8 (3.5, 5.8)
|
7.9 (7.2, 8.7)
|
11.4 (10.3, 13.6)
| |
4.8 (3.5, 5.8)
|
7.9 (7.2, 8.7)
|
11.4 (10.3, 13.6)
| |
|
Age – adjusted
|
1.00
|
0.78 (0.47, 1.30)
|
0.68 (0.41, 1.14)
|
0.15
|
1.00
|
1.01 (0.62, 1.64)
|
0.80 (0.49, 1.30)
|
0.37
|
|
Model 1
|
1.00
|
0.80 (0.47, 1.35)
|
0.63 (0.37, 1.08)
|
0.09
|
1.00
|
1.00 (0.60, 1.65)
|
0.79 (0.48, 1.30)
|
0.34
|
|
Model 2
|
1.00
|
0.81 (0.47, 1.37)
|
0.62 (0.36, 1.07)
|
0.08
|
1.00
|
1.00 (0.61, 1.66)
|
0.76 (0.46, 1.26)
|
0.29
|
|
Isoleucine
|
|
cases/total
|
47/141
|
44/141
|
37/141
| |
61/141
|
63/141
|
54/141
| |
|
Median (IQR) intake (g/d)a
|
1.1 (0.8, 1.5)
|
2.0 (1.8, 2.2)
|
2.9 (2.6, 3.5)
| |
1.1 (0.8, 1.5)
|
2.0 (1.8, 2.2)
|
2.9 (2.6, 3.5)
| |
|
Age – adjusted
|
1.00
|
0.88 (0.53, 1.45)
|
0.69 (0.41, 1.15)
|
0.16
|
1.00
|
1.01 (0.62, 1.63)
|
0.77 (0.47, 1.25)
|
0.29
|
|
Model 1
|
1.00
|
0.91 (0.53, 1.54)
|
0.64 (0.37, 1.10)
|
0.10
|
1.00
|
1.01 (0.61, 1.66)
|
0.76 (0.46, 1.25)
|
0.28
|
|
Model 2
|
1.00
|
0.91 (0.53, 1.55)
|
0.64 (0.37, 1.09)
|
0.10
|
1.00
|
1.00 (0.60, 1.66)
|
0.74 (0.45, 1.23)
|
0.24
|
|
Leucine
|
|
cases/total
|
50/141
|
39/141
|
39/141
| |
65/141
|
57/141
|
56/141
| |
|
Median (IQR) intake (g/d)a
|
2.1 (1.5, 2.5)
|
3.5 (3.2, 3.9)
|
5.4 (4.6, 5.9)
| |
2.1 (1.5, 2.5)
|
3.5 (3.2, 3.9)
|
5.4 (4.6, 5.9)
| |
|
Age – adjusted
|
1.00
|
0.66 (0.40, 1.11)
|
0.67 (0.40, 1.11)
|
0.12
|
1.00
|
0.73 (0.45, 1.19)
|
0.71 (0.44, 1.16)
|
0.18
|
|
Model 1
|
1.00
|
0.66 (0.39, 1.14)
|
0.64 (0.38, 1.08)
|
0.10
|
1.00
|
0.68 (0.41, 1.14)
|
0.71 (0.43, 1.16)
|
0.19
|
|
Model 2
|
1.00
|
0.67 (0.39, 1.16)
|
0.63 (0.37, 1.07)
|
0.09
|
1.00
|
0.68 (0.41, 1.14)
|
0.69 (0.41, 1.13)
|
0.15
|
|
Valine
|
|
cases/total
|
45/141
|
44/141
|
39/141
| |
57/141
|
65/141
|
56/141
| |
|
Median (IQR) intake (g/d)a
|
1.4 (1.0, 1.8)
|
2.4 (2.2, 2.6)
|
3.4 (3.1, 3.9)
| |
1.4 (1.0, 1.8)
|
2.4 (2.2, 2.6)
|
3.4 (3.1, 3.9)
| |
|
Age – adjusted
|
1.00
|
0.91 (0.55, 1.52)
|
0.78 (0.46, 1.31)
|
0.35
|
1.00
|
1.15 (0.71, 1.87)
|
0.90 (0.55, 1.48)
|
0.68
|
|
Model 1
|
1.00
|
0.94 (0.55, 1.60)
|
0.74 (0.43, 1.26)
|
0.27
|
1.00
|
1.16 (0.70, 1.92)
|
0.91 (0.55, 1.49)
|
0.68
|
|
Model 2
|
1.00
|
0.95 (0.55, 1.61)
|
0.73 (0.43, 1.25)
|
0.25
|
1.00
|
1.16 (0.70, 1.92)
|
0.88 (0.53, 1.46)
|
0.60
|
- aBranched-chain amino acids were adjusted for energy intake using the residual method; IQR Interquartile range; Model 1 was adjusted for age (in years, continuous), year of stay (≤4years, 5-9years, ≥10years), education (elementary to high school, college education and above), employment (no, yes), ever smoke (no, yes), current alcohol use (no, yes) and energy intake (in kcal/d, continuous). Model 2 was adjusted for history of diabetes (no, yes) and hypertension (no, yes) in addition to variables in model 1
